Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
Evaluating the Inhibitory Effects of Human Wharton’s Jelly Stem Cells on Acute Myeloid Leukemia Cell Line (K562) in vitro
تقييم الأثار المثبطة للخلايا الجذعية الهلامية على خط خلايا سرطان الدم الحاد الغير ليمفاوي في المختبر
Subject
:
Faculty of Applied Medical Sciences
Document Language
:
Arabic
Abstract
:
Acute myeloid leukemia (AML) is the most common form of leukemia and has high mortality with delayed treatment. Despite therapeutic advances, the cytotoxic side effects and poor prognosis in adults remain a great concern. Recently, human mesenchymal stem cells (MSCs) have been reported to have anticancer properties and is therefore considered to be a novel in cancer therapeutics. Of the existing stem cell types, the human umbilical cord derived Wharton’s jelly stem cells (hWJSCs) have several advantages, such as wide multipotency, hypoimmunogenicity, non-tumorigenic and anticancer properties. As such in the present thesis we evaluated the anticancer properties of hWJSCs against an AML cell line (K562) in vitro. Derived hWJSCs demonstrated the MSCs related CD markers expression using fluorescent activated cell sorting (FACS). The K562 cells treated with hWJSCs (co-culture), or its extracts namely, hWJSC-CM (100%) or hWJSC-CL (15 μg/mL) showed decrease in K562 cells proliferation and morphological changes leading to cell death at 24 h, 48 h and 72 h. AnnexinV-APC analysis showed the presence of apoptotic cells following treatment with hWJSCs co-culture (by 3.8% & 4.0%); hWJSC-CM (by 7.1% & 3.8%) and hWJSC-CL (by 9.2% & 4.5%) at both 24 h and 48 h respectively. Cell cycle analysis in general showed G2/M phase arrest following treatment with hWJSCs co-culture, hWJSC-CM and hWJSC-CL at both 24 h and 48 h. qRT-PCR showed downregulation of pro-apoptotic BAX genes compared anti-apoptotic genes (BCL2 and SURVIVIN) following treatment with hWJSCs and its extracts. Also, the cell cycle (CYCLIN A2 and CYCLIN E1) and inflammation related genes (IL-6, TNF),) were downregulated. The above studies indicate that hWJSCs and its extracts (hWJSC-CM and hWJSC-CL) inhibit K562 cell line in vitro and hope that identification of the specific molecules responsible for these inhibitory effects will pave way for novel therapeutics against acute myelogenous leukemia.
Supervisor
:
Dr. Clamigam Gotman
Thesis Type
:
Master Thesis
Publishing Year
:
1441 AH
2020 AD
Added Date
:
Wednesday, June 3, 2020
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
منيرة عبد الحليم حويكم
Huwaikem, Muneerah Abdul Halim
Researcher
Master
Files
File Name
Type
Description
46286.pdf
pdf
Back To Researches Page